1. Home
  2. UVE vs MLTX Comparison

UVE vs MLTX Comparison

Compare UVE & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UNIVERSAL INSURANCE HOLDINGS INC

UVE

UNIVERSAL INSURANCE HOLDINGS INC

HOLD

Current Price

$34.53

Market Cap

925.9M

Sector

Finance

ML Signal

HOLD

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

HOLD

Current Price

$13.87

Market Cap

972.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UVE
MLTX
Founded
1990
2021
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
925.9M
972.7M
IPO Year
1992
N/A

Fundamental Metrics

Financial Performance
Metric
UVE
MLTX
Price
$34.53
$13.87
Analyst Decision
Buy
Buy
Analyst Count
1
9
Target Price
$40.00
$36.33
AVG Volume (30 Days)
163.7K
1.8M
Earning Date
10-23-2025
11-05-2025
Dividend Yield
2.20%
N/A
EPS Growth
70.32
N/A
EPS
4.23
N/A
Revenue
$1,580,798,000.00
N/A
Revenue This Year
$1.87
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$8.29
N/A
Revenue Growth
4.61
N/A
52 Week Low
$18.72
$5.95
52 Week High
$35.84
$62.75

Technical Indicators

Market Signals
Indicator
UVE
MLTX
Relative Strength Index (RSI) 61.37 49.48
Support Level $32.50 $13.32
Resistance Level $35.40 $15.40
Average True Range (ATR) 0.95 0.77
MACD 0.19 -0.05
Stochastic Oscillator 80.71 31.64

Price Performance

Historical Comparison
UVE
MLTX

About UVE UNIVERSAL INSURANCE HOLDINGS INC

Universal Insurance Holdings Inc is a private personal residential homeowner insurance company. The company develops, markets, and underwrites insurance products for consumers predominantly in the personal residential homeowners' lines of business and performs substantially all other insurance-related services for its primary insurance entities, including risk management, claims management, and distribution. The company generates revenue from the collection of premiums, earned net interest and dividend income from the investment portfolio, the collection of reinsurance recoverable and financing fees. The company's primary insurance subsidiaries, (UPCIC) and (APPCIC) provide insurance for personal residential: homeowners, renters/tenants, condo unit owners, and other related coverages.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

Share on Social Networks: